Humanin vs Mots C
Which Is Right for You? Complete Comparison (2026)
Humanin vs MOTS-c — two mitochondrial-encoded anti-aging peptides. Humanin prevents cell death and neurodegeneration.
Humanin vs Mots C: At a Glance
- ✓Mitochondrial DNA-encoded 24-amino acid cytoprotective peptide
- ✓Prevents apoptosis via interaction with Bax and IGFBP-3
- ✓Neuroprotective — blocks amyloid-beta toxicity in neurons
- ✓Improves peripheral insulin sensitivity
- ✓Levels decline with age — correlates with age-related disease
- ✓Mitochondrial DNA-encoded 16-amino acid peptide (mitokine)
- ✓Activates AMPK and SIRT1 signalling pathways
- ✓Improves insulin sensitivity and fat oxidation
- ✓Mimics beneficial metabolic effects of exercise
- ✓Translocates to nucleus to regulate gene expression
Detailed Comparison
| Feature | Humanin | Mots C |
|---|---|---|
| Mechanism | Mitochondrial-derived cytoprotective peptide | Mitochondrial-derived exercise mimetic peptideBest |
| Dosing | Research doses vary; HNG analogue 1-4 mg SC | 5-10 mg SC 3-5x weekly |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Half-life | Short (~minutes for native form); analogues longer | Not well-characterized in humans (~hours) |
| FDA Status | Not FDA-approved — research peptide | Not FDA-approved — research peptide |
| Key Trial | Hashimoto Y et al. PNAS 2001 — neuroprotective discovery | Lee C et al. Cell Metab 2015 — metabolic homeostasis and obesity |
| Side Effects | Limited human data; generally well-tolerated in preclinical studies | Limited human data; injection site reactions reported |
Which Should You Choose?
Humanin (mitochondrial-derived cytoprotective peptide) and MOTS-c (mitochondrial-derived exercise mimetic peptide) target different aspects of health despite overlapping interest areas. Humanin mitochondrial dna-encoded 24-amino acid peptide that prevents apoptosis, protects neurons from amyloid-beta toxicity, and improves insulin sensitivity. MOTS-c mitochondrial-encoded 16-amino acid peptide that activates ampk signalling, improves metabolic homeostasis, and mimics exercise benefits at the cellular level.
Whichever you choose, track your protocol in Shotlee to build clean data for dose optimization and outcomes comparison.
Making an Informed Choice Between Humanin and Mots C
Choosing between Humanin and Mots C depends on multiple individual factors including your specific health goals, tolerance profile, insurance coverage, and prescriber recommendation. While clinical trial data provides population-level efficacy and safety comparisons, your personal response may differ based on genetics, baseline health, concurrent conditions, and lifestyle factors. Use this comparison as a starting framework and discuss the specifics with your healthcare provider.
Head-to-head clinical trial data between Humanin and Mots C is the gold standard for comparison, but such direct comparisons are not always available for every pair of compounds. Where head-to-head data is lacking, cross-trial comparisons provide useful but imperfect approximations — differences in patient populations, trial design, and endpoint definitions mean that numbers from separate trials are not directly interchangeable. Keep this context in mind when evaluating the comparison data presented here.
Tracking your personal response data in Shotlee is particularly valuable when switching between medications or considering a change. By documenting your outcomes on your current protocol — including efficacy metrics, side effect profile, adherence rate, and quality of life measures — you create an objective baseline for comparison if you transition to the alternative compound. This data transforms a subjective switching decision into an evidence-based protocol optimization.
Humanin vs Mots C: Frequently Asked Questions
Humanin is a mitochondrial-derived cytoprotective peptide while MOTS-c is a mitochondrial-derived exercise mimetic peptide. They differ in mechanism, dosing, and clinical evidence. Your choice should depend on your specific goals and medical history.
Switching should be done under medical supervision. Your prescriber can advise on transition protocols. Track both in Shotlee for comparison data.
Humanin works as a mitochondrial-derived cytoprotective peptide (Research doses vary; HNG analogue 1-4 mg SC), while MOTS-c is a mitochondrial-derived exercise mimetic peptide (5-10 mg SC 3-5x weekly). They have different half-lives (Short (~minutes for native form); analogues longer vs Not well-characterized in humans (~hours)), side effect profiles, and levels of clinical evidence.
Yes. Shotlee supports tracking any medication or peptide. You can compare your results across different protocols.
Neither is universally better — the right choice depends on your individual health profile, treatment goals, side effect tolerance, insurance coverage, and prescriber recommendation. Clinical trial data shows efficacy differences in specific populations, but personal response varies. Track your experience with either medication in Shotlee to generate objective comparison data with your healthcare provider.
Switching between these medications should be done under medical supervision. Your prescriber will consider factors including your current response, reason for switching, dose equivalence, and transition timing. Use Shotlee to document your outcomes on the current medication so you have a clear baseline for comparison after switching.
Track Humanin or Mots C in Shotlee
Free dose tracking, side effect logging, and outcome comparison for any medication protocol.